• Stable patients in an OTP may receive 28 days of take-home doses of the patient’s medication for opioid use disorder.
• Up to 14 days of take-home medication for those patients who are less stable but who the OTP believes can safely handle this level of Take-Home medication.

1. N.C.G.S. § 122C-3(14) defines a “licensable facility” as “a facility for one or more minors or for two or more adults that provides services to individuals who have mentally illness or intellectual or other developmental disabilities, or substance abusers. These services shall be day services offered to the same individual for a period of three hours or more during a 24-hour period, or residential services provided for 24 consecutive hours or more. Facilities for individuals who are substance abusers include chemical dependency facilities.”
2. N.C.G.S. § 122C-21 states the purpose of the licensure laws. The purpose of the licensure laws and rules is to provide for licensure of facilities for individuals with mental health disorders, developmental disabilities, and substance use disorders by the development, establishment, and enforcement of basic rules governing the provision of services to individuals who receive services from licensable facilities and the construction, maintenance, and operation of these licensable facilities that, based on existing knowledge, will ensure safe and adequate treatment of these individuals.
3. N.C.G.S. § 122C-23(a) states “No person shall establish, maintain, or operate a licensable facility for individuals with mental illness, individuals with intellectual or other developmental disabilities, or substance abusers without a current license issued by the Secretary.”
4. 10A NCAC 27G .5601(a) defines “Supervised living” as “a 24-hour facility which provides residential services to individuals in a home environment where the primary purposes of these services is the care, habilitation, or rehabilitation of individuals who have a mental illness, a developmental disability or disabilities, or a substance abuse disorder, and who require supervision when in the residence.”
5. 10A NCAC 27G .5601(b) requires that a supervised living facility “be licensed if the facility serves either: (1) one or more minor clients; or (2) two or more adult clients.”
6. N.C.G.S. § 122C-28 states: “Operating a licensable facility without a license is a Class H felony, including a fine of one thousand dollars ($1,000) per day that the facility is in operation in violation of [Article 2 of Chapter 122C of the General Statutes].”

• Contracting for physical and behavioral health
• Understanding Tailored Care Management and how it differs from Standard Plan
• Safeguarding Transitions of Care when members move between plans

• Skilled Nursing Facility Reimbursement Methodology Revisions
• Electronic Visit Verification Home Health Provider Agency Survey
• Quarterly Drug HCPCS Code Update July 1, 2022
• Leuprolide Injectable Emulsion, for Subcutaneous Use (Camcevi™) HCPCS Code J1952: Billing Guidelines
• Lanreotide Injection, for Subcutaneous Use HCPCS Code J3490: Billing Guidelines
• Facility-Based Crisis Service for Children and Adolescents Policy Updated
• Integrating Community Health Workers into NC Medicaid 

• Submit PA requests 
• Inquire about PA requests 

• Understand the provider enrollment application processes
• Navigate to the NCTracks provider portal and complete the following provider enrollment application processes:
• Provider enrollment
• MCR 
• Re-enrollment
• Re-verification
• Maintain eligibility

• Submit dental PA requests
• Inquire about dental PA requests

• Submit PA requests electronically 
• Conduct electronic inquiries about PA requests

• Update the OA for an individual provider, organization, or atypical provider
• Upgrade existing users by managing relationships

• SPECIAL BULLETIN COVID-19 #254: Pfizer-BioNTech COVID-19 Vaccine: Primary Series for Children Ages 6 Months to Under 5 Years
•  SPECIAL BULLETIN COVID-19 #256: Moderna COVID-19 Vaccine – Primary Series for Children 6 Months Through 5 Years of Age
•  SPECIAL BULLETIN COVID-19 #257: Moderna Pediatric Vaccine Primary Series for Children Ages 6 Through 11 Years
•  Pharmacy Point of Sale Overrides
•  North Carolina Medicaid Pharmacy Point of Sale Billing for Pharmacist Prescribed Paxlovid 

• North Carolina’s leaders need to know about the issues affecting the I/DD DSP workforce
• The family members and individuals living with I/DD need the support 

• Disproportionalities and Disparities in Child Welfare: A Supplement to Understanding Substance Use Disorder, Treatment, and Family Recovery: A Guide for Child Welfare Professionals helps child welfare supervisors and staff: 1) understand the link between disproportionalities, disparities, and the child welfare system; 2) recognize disproportionalities and disparities when working with families affected by substance use disorders (SUD); and 3) implement strategies to increase family engagement and reduce inequities. Understanding Substance Use Disorder, Treatment, and Family Recovery: A Guide for Child Welfare Professionals is a self-paced online tutorial that offers 4.5 continuing education units (CEUs). 
• Key Considerations for Applying an Equity Lens to Collaborative Practice explains how collaborative teams can assess existing policies to determine if and how they contribute to disproportionate and disparate outcomes for families. By working through the “Questions to Consider,” teams begin applying an equity lens to collaborative policies and practices. This brief serves as a companion to the Comprehensive Framework to Improve Outcomes for Families Affected by Substance Use Disorders and Child Welfare Involvement. Children and Family Futures developed the framework as a set of proven strategies to improve outcomes with equity for all children, parents, and families affected by trauma, substance use, and mental disorders.
• Disrupting Stigma: A Virtual Conversation discusses how stigma relates to substance use, mental disorders, and child welfare involvement. This webinar also: 1) highlights how stigma affects professionals, families, and existing institutions and structures; 2) identifies how bias, stereotypes, and stigma develop; and 3) offers strategies to effectively modify policy and practice. The companion to this webinar is Disrupting Stigma: How Understanding, Empathy, and Connection Can Improve Outcomes for Families Affected by Substance Use and Mental Disorders.